ZNF205
gene geneOn this page
Also known as Zfp13
Summary
ZNF205 (zinc finger protein 205, HGNC:12996) is a protein-coding gene on chromosome 16p13.3, encoding Transcriptional repressor RHIT (O95201). Transcriptional repressor involved in regulating MPV17L expression.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II; positive regulation of hydrogen peroxide biosynthetic process; and positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. Predicted to be located in mitochondrion and nucleus.
Source: NCBI Gene 7755 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_001042428
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12996 |
| Approved symbol | ZNF205 |
| Name | zinc finger protein 205 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Zfp13 |
| Ensembl gene | ENSG00000122386 |
| Ensembl biotype | protein_coding |
| OMIM | 603436 |
| Entrez | 7755 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 protein_coding
ENST00000219091, ENST00000382192, ENST00000414351, ENST00000444510, ENST00000570935, ENST00000620094, ENST00000871314, ENST00000871315, ENST00000871316, ENST00000871317, ENST00000871318, ENST00000871319, ENST00000871320, ENST00000922265, ENST00000922266
RefSeq mRNA: 3 — MANE Select: NM_001042428
NM_001042428, NM_001278158, NM_003456
CCDS: CCDS10494
Canonical transcript exons
ENST00000219091 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000665990 | 3115829 | 3115920 |
| ENSE00000666011 | 3116427 | 3116547 |
| ENSE00000666021 | 3118905 | 3119015 |
| ENSE00001293954 | 3119256 | 3120517 |
| ENSE00001350470 | 3113417 | 3113487 |
| ENSE00001491197 | 3115355 | 3115568 |
| ENSE00001942893 | 3112586 | 3112682 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 97.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.5508 / max 70.6191, expressed in 1577 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 152396 | 7.5508 | 1577 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 97.91 | gold quality |
| vena cava | UBERON:0004087 | 90.80 | gold quality |
| parotid gland | UBERON:0001831 | 90.58 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 90.37 | silver quality |
| medial globus pallidus | UBERON:0002477 | 90.09 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 89.54 | gold quality |
| globus pallidus | UBERON:0001875 | 88.58 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 87.53 | gold quality |
| triceps brachii | UBERON:0001509 | 87.13 | gold quality |
| body of tongue | UBERON:0011876 | 86.72 | gold quality |
| gluteal muscle | UBERON:0002000 | 86.40 | silver quality |
| apex of heart | UBERON:0002098 | 85.46 | gold quality |
| cortical plate | UBERON:0005343 | 84.32 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 84.27 | gold quality |
| pylorus | UBERON:0001166 | 84.03 | gold quality |
| tongue | UBERON:0001723 | 83.94 | gold quality |
| cardia of stomach | UBERON:0001162 | 83.72 | gold quality |
| upper arm skin | UBERON:0004263 | 83.57 | silver quality |
| nipple | UBERON:0002030 | 83.31 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 83.13 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.03 | gold quality |
| pons | UBERON:0000988 | 82.98 | gold quality |
| inferior olivary complex | UBERON:0002127 | 82.98 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 82.70 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 82.47 | silver quality |
| inferior vagus X ganglion | UBERON:0005363 | 82.30 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 82.27 | silver quality |
| ventral tegmental area | UBERON:0002691 | 82.20 | gold quality |
| saphenous vein | UBERON:0007318 | 82.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.68 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| MPV17 | Repression |
| MPV17L | Unknown |
Upstream regulators (CollecTRI, top): FOXP3, GABPA, STAT1
miRNA regulators (miRDB)
4 targeting ZNF205, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-1245B-5P | 98.88 | 66.55 | 576 |
| HSA-MIR-3142 | 98.88 | 66.09 | 529 |
| HSA-MIR-6872-3P | 97.08 | 66.99 | 750 |
Literature-anchored findings (GeneRIF, showing 2)
- that knockdown of RhitH or overexpression of M-LPH reduces the generation of intracellular H(2)O(2) and loss of mitochondrial membrane potential caused by an inhibitor of the respiratory chain, antimycin A (PMID:22306510)
- ZNF205 positively regulates RLR antiviral signaling by targeting RIG-I. (PMID:37580950)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp13 | ENSMUSG00000062012 |
| rattus_norvegicus | Zfp13 | ENSRNOG00000003455 |
Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
Transcriptional repressor RHIT — O95201 (reviewed: O95201)
Alternative names: Repressor of heat-inducible transcription, Zinc finger protein 205, Zinc finger protein 210
All UniProt accessions (4): C9JEY6, C9JS60, O95201, I3L417
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor involved in regulating MPV17L expression. By regulating MPV17L expression, contributes to the regulation of genes involved in H(2)O(2) metabolism and the mitochondrial apoptotic cascade.
Subcellular location. Nucleus.
Tissue specificity. Expressed in heart, skeletal muscle, pancreas and brain. Weakly expressed in placenta, lung, liver, kidney and thymus.
Domain organisation. The KRAB domain is required for transcriptional repression.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001035893, NP_001265087, NP_003447 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050331 | Zinc_finger_PRDM4/PRDM1/PRDM14 | Family |
Pfam: PF00096, PF01352
UniProt features (20 total): zinc finger region 8, region of interest 3, compositionally biased region 3, sequence variant 2, chain 1, domain 1, modified residue 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95201-F1 | 63.49 | 0.21 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 292, 219
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 114 (showing top):
BROWNE_HCMV_INFECTION_30MIN_DN, GCANCTGNY_MYOD_Q6, GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS, HUMMERICH_BENIGN_SKIN_TUMOR_UP, GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION, GOBP_MITOCHONDRIAL_TRANSPORT, GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS, GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION, GOBP_APOPTOTIC_SIGNALING_PATHWAY, BROWNE_HCMV_INFECTION_14HR_DN, GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS, RYTTCCTG_ETS2_B, GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY, ELK1_01
GO Biological Process (6): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), positive regulation of hydrogen peroxide biosynthetic process (GO:0010729), positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030), positive regulation of biosynthetic process (GO:0009891)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), mitochondrion (GO:0005739)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| intracellular membrane-bounded organelle | 2 |
| negative regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| regulation of hydrogen peroxide biosynthetic process | 1 |
| hydrogen peroxide biosynthetic process | 1 |
| positive regulation of reactive oxygen species biosynthetic process | 1 |
| positive regulation of organelle organization | 1 |
| positive regulation of mitochondrial membrane permeability | 1 |
| positive regulation of transport | 1 |
| mitochondrial outer membrane permeabilization | 1 |
| regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1 |
| biosynthetic process | 1 |
| regulation of biosynthetic process | 1 |
| positive regulation of metabolic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| transcription cis-regulatory region binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
714 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF205 | OR1F1 | O43749 | 887 |
| ZNF205 | MEFV | O15553 | 717 |
| ZNF205 | COQ9 | O75208 | 540 |
| ZNF205 | NEU2 | Q9Y3R4 | 520 |
| ZNF205 | NAT9 | Q9BTE0 | 518 |
| ZNF205 | SVOPL | Q8N434 | 502 |
| ZNF205 | GCGR | P47871 | 474 |
| ZNF205 | PAFAH1B3 | Q15102 | 444 |
| ZNF205 | CCNP | Q9H8S5 | 439 |
| ZNF205 | MPV17L | Q2QL34 | 419 |
| ZNF205 | BST2 | Q10589 | 408 |
| ZNF205 | EP300 | Q09472 | 398 |
| ZNF205 | SEC61G | P38384 | 398 |
| ZNF205 | PLA2G1B | P04054 | 359 |
| ZNF205 | RAB15 | P59190 | 359 |
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF205 | TNS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF205 | TSGA10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF205 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF205 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN4 | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.510 |
| ZNF205 | C8orf33 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF205 | CDC37 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HDAC6 | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF205 | ILK | psi-mi:“MI:0915”(physical association) | 0.370 |
| MAPK6 | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MEST | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.370 |
| WT1 | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF205 | CCDC85B | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF205 | CALCOCO2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRAF2 | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MDFI | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TNS2 | ZNF205 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF205 | TSGA10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF205 | GOLGA6L9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF205 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF205 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF205 | UBQLN4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): CCDC85B (Two-hybrid), CALCOCO2 (Two-hybrid), ZNF205 (Two-hybrid), ZNF205 (Two-hybrid), ZNF205 (Affinity Capture-MS), ZNF205 (Affinity Capture-MS), ZNF205 (Affinity Capture-RNA), ZNF205 (Two-hybrid), ZNF205 (Two-hybrid), TSGA10 (Two-hybrid), UBQLN2 (Two-hybrid), GOLGA6L9 (Two-hybrid), ZNF205 (Affinity Capture-RNA), ZNF205 (Two-hybrid), ZNF205 (Two-hybrid)
ESM2 similar proteins: A1YGK1, A2T7E6, A4D1S0, A9YTQ3, B1WBS3, I7HJS4, O43593, O43918, O60304, O75593, O95201, P0C6A0, P0C7X2, P97609, Q2MHN3, Q3B7M4, Q3SY56, Q3U133, Q58DK7, Q5JPB2, Q5SXI5, Q5T619, Q61645, Q6KAU7, Q6NUN9, Q6ZMS7, Q76NI1, Q7Z6P3, Q8BZ34, Q8BZW2, Q8CGW9, Q8IWN7, Q8IXT2, Q8IZ20, Q8NBB4, Q8NDX1, Q8NHY3, Q91X45, Q96PX9, Q99558
Diamond homologs: A2T736, A3KN32, A3KN36, A6NFI3, A6NP11, A6QPT6, A8MT65, B2RXC5, B4DU55, B4DXR9, O14978, O43296, O60765, O95125, O95201, P0CB33, P0DPD5, P10754, P15622, P17036, P17098, P21506, P51508, P51815, Q02975, Q08DG8, Q08ER8, Q13106, Q13360, Q15776, Q15973, Q29RZ4, Q32M78, Q3SXZ3, Q4R8H9, Q4V8E9, Q571J5, Q58DK7, Q5CZA5, Q5FWF6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1569 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:3115487:G:GT | donor_gain | 1.0000 |
| 16:3115827:A:AG | acceptor_gain | 1.0000 |
| 16:3115828:G:GG | acceptor_gain | 1.0000 |
| 16:3115828:GCC:G | acceptor_gain | 1.0000 |
| 16:3116514:G:T | donor_gain | 1.0000 |
| 16:3116544:CTGG:C | donor_gain | 1.0000 |
| 16:3116545:TGG:T | donor_gain | 1.0000 |
| 16:3116546:GG:G | donor_gain | 1.0000 |
| 16:3116546:GGG:G | donor_gain | 1.0000 |
| 16:3116547:GG:G | donor_gain | 1.0000 |
| 16:3116548:G:GG | donor_gain | 1.0000 |
| 16:3116548:GT:G | donor_loss | 1.0000 |
| 16:3116549:T:G | donor_loss | 1.0000 |
| 16:3113485:G:GT | donor_gain | 0.9900 |
| 16:3115353:AG:A | acceptor_gain | 0.9900 |
| 16:3115354:GG:G | acceptor_gain | 0.9900 |
| 16:3115490:G:GT | donor_gain | 0.9900 |
| 16:3115533:GCTC:G | donor_gain | 0.9900 |
| 16:3115823:CCACA:C | acceptor_loss | 0.9900 |
| 16:3115824:CACA:C | acceptor_loss | 0.9900 |
| 16:3115825:ACAG:A | acceptor_loss | 0.9900 |
| 16:3115826:CA:C | acceptor_loss | 0.9900 |
| 16:3115828:GC:G | acceptor_gain | 0.9900 |
| 16:3115828:GCCC:G | acceptor_gain | 0.9900 |
| 16:3115828:GCCCT:G | acceptor_gain | 0.9900 |
| 16:3116543:ACTGG:A | donor_gain | 0.9900 |
| 16:3119251:TCCAG:T | acceptor_loss | 0.9900 |
| 16:3119252:CCAG:C | acceptor_loss | 0.9900 |
| 16:3119254:A:AG | acceptor_gain | 0.9900 |
| 16:3119255:G:GG | acceptor_gain | 0.9900 |
AlphaMissense
3614 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:3119777:T:C | F373L | 1.000 |
| 16:3119779:C:A | F373L | 1.000 |
| 16:3119779:C:G | F373L | 1.000 |
| 16:3119861:T:C | F401L | 1.000 |
| 16:3119863:C:A | F401L | 1.000 |
| 16:3119863:C:G | F401L | 1.000 |
| 16:3119945:T:C | F429L | 1.000 |
| 16:3119947:C:A | F429L | 1.000 |
| 16:3119947:C:G | F429L | 1.000 |
| 16:3120029:T:C | F457L | 1.000 |
| 16:3120031:C:A | F457L | 1.000 |
| 16:3120031:C:G | F457L | 1.000 |
| 16:3120048:T:C | L463P | 1.000 |
| 16:3120063:G:C | R468P | 1.000 |
| 16:3120113:T:C | F485L | 1.000 |
| 16:3120114:T:C | F485S | 1.000 |
| 16:3120115:C:A | F485L | 1.000 |
| 16:3120115:C:G | F485L | 1.000 |
| 16:3120132:T:C | L491P | 1.000 |
| 16:3120197:T:C | F513L | 1.000 |
| 16:3120198:T:C | F513S | 1.000 |
| 16:3120199:C:A | F513L | 1.000 |
| 16:3120199:C:G | F513L | 1.000 |
| 16:3119609:T:C | F317L | 0.999 |
| 16:3119611:C:A | F317L | 0.999 |
| 16:3119611:C:G | F317L | 0.999 |
| 16:3119693:T:C | F345L | 0.999 |
| 16:3119695:C:A | F345L | 0.999 |
| 16:3119695:C:G | F345L | 0.999 |
| 16:3119804:C:G | H382D | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000057340 (16:3117352 G>A), RS1000131613 (16:3111222 G>A,C), RS1000341512 (16:3115738 G>A,T), RS1000561731 (16:3113896 AGT>A,AGTGT,AGTGTGT), RS1001020560 (16:3115616 G>T), RS1001060113 (16:3118632 C>A,T), RS1001193096 (16:3111852 G>A), RS1002049966 (16:3113598 G>A,C,T), RS1002081075 (16:3113373 GC>G), RS1002300888 (16:3118351 A>G), RS1002401744 (16:3115981 G>A,T), RS1002665369 (16:3117489 C>A,G), RS1002738968 (16:3117194 G>C), RS1002938481 (16:3112681 C>T), RS1003250107 (16:3113892 G>A)
Disease associations
OMIM: gene MIM:603436 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| butyraldehyde | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Particulate Matter | increases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.